CHICAGO — A speaker at the American Society for Dermatologic Surgery Annual Meeting discussed how a multidisciplinary approach may be necessary for the treatment of in-transit melanoma.“ [In ...

It was conventionally thought that TVEC worked by activating T cells – a type of white blood cell – causing them to attack the cancer cells and shrink the melanoma.

AI-powered quantification of tumor-infiltrating lymphocytes could change how patients with melanoma are treated after surgery ...

Here, we used tissue from a pilot phase II study (N = 6; Appendix Table A1) exploring the use of oncolytic virus (OV), talimogene laherparepvec (TVEC), to stimulate an immune response before standard ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control when compared to giving treatments over a longer period, according to ...